Cargando…
CDK4/6 inhibition enhances SHP2 inhibitor efficacy and is dependent upon restoration of RB function in malignant peripheral nerve sheath tumors
Malignant peripheral nerve sheath tumors (MPNST) are highly aggressive soft tissue sarcomas with limited treatment options, and novel effective therapeutic strategies are desperately needed. We observe anti-proliferative efficacy of genetic depletion or pharmacological inhibition using the clinicall...
Autores principales: | Wang, Jiawan, Calizo, Ana, Zhang, Lindy, Pino, James C., Lyu, Yang, Pollard, Kai, Zhang, Xiaochun, Larsson, Alex T., Conniff, Eric, Llosa, Nicolas, Wood, David K., Largaespada, David A., Moody, Susan E., Gosline, Sara J., Hirbe, Angela C., Pratilas, Christine A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cold Spring Harbor Laboratory
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9915673/ https://www.ncbi.nlm.nih.gov/pubmed/36778419 http://dx.doi.org/10.1101/2023.02.02.526674 |
Ejemplares similares
-
CDK4/6 inhibition enhances SHP2 inhibitor efficacy and is dependent upon RB function in malignant peripheral nerve sheath tumors
por: Wang, Jiawan, et al.
Publicado: (2023) -
Ex vivo to in vivo model of malignant peripheral nerve sheath tumors for precision oncology
por: Larsson, Alex T, et al.
Publicado: (2023) -
From Genes to -Omics: The Evolving Molecular Landscape of Malignant Peripheral Nerve Sheath Tumor
por: Lemberg, Kathryn M., et al.
Publicado: (2020) -
Special Issue: “Genomics and Models of Nerve Sheath Tumors”
por: Hirbe, Angela C., et al.
Publicado: (2020) -
A clinically and genomically annotated nerve sheath tumor biospecimen repository
por: Pollard, Kai, et al.
Publicado: (2020)